DE2323723A1 - Verfahren zur herstellung von neuen derivaten der p-dihydroxybenzoldisulfonsaeure - Google Patents

Verfahren zur herstellung von neuen derivaten der p-dihydroxybenzoldisulfonsaeure

Info

Publication number
DE2323723A1
DE2323723A1 DE2323723A DE2323723A DE2323723A1 DE 2323723 A1 DE2323723 A1 DE 2323723A1 DE 2323723 A DE2323723 A DE 2323723A DE 2323723 A DE2323723 A DE 2323723A DE 2323723 A1 DE2323723 A1 DE 2323723A1
Authority
DE
Germany
Prior art keywords
acid
salt
dihydroxybenzenesulfonic
cation
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2323723A
Other languages
German (de)
English (en)
Other versions
DE2323723C2 (ro
Inventor
Antonio Esteve-Subirana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provesan SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH732672A external-priority patent/CH550148A/fr
Priority claimed from CH115473A external-priority patent/CH558340A/fr
Application filed by Individual filed Critical Individual
Publication of DE2323723A1 publication Critical patent/DE2323723A1/de
Application granted granted Critical
Publication of DE2323723C2 publication Critical patent/DE2323723C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2323723A 1972-05-17 1973-05-10 Verfahren zur herstellung von neuen derivaten der p-dihydroxybenzoldisulfonsaeure Granted DE2323723A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH732672A CH550148A (fr) 1972-05-17 1972-05-17 Procede de preparation de sels d'acides p-dihydroxybenzenedisulfoniques.
CH115473A CH558340A (en) 1973-01-26 1973-01-26 Dihydroxybenzenedisulphonic acid derivs - prepd from dihydroxybenzene - disulphonic acid and base

Publications (2)

Publication Number Publication Date
DE2323723A1 true DE2323723A1 (de) 1973-11-29
DE2323723C2 DE2323723C2 (ro) 1987-08-13

Family

ID=25686824

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2323723A Granted DE2323723A1 (de) 1972-05-17 1973-05-10 Verfahren zur herstellung von neuen derivaten der p-dihydroxybenzoldisulfonsaeure

Country Status (15)

Country Link
JP (1) JPS5716982B2 (ro)
AR (1) AR204506A1 (ro)
CA (1) CA1024146A (ro)
CS (1) CS194162B2 (ro)
DD (1) DD107025A5 (ro)
DE (1) DE2323723A1 (ro)
ES (1) ES414365A1 (ro)
FR (1) FR2201888B1 (ro)
GB (1) GB1419995A (ro)
HU (1) HU169471B (ro)
NL (1) NL179186C (ro)
PL (1) PL93785B1 (ro)
RO (2) RO72544A (ro)
SE (1) SE416729B (ro)
YU (1) YU41547B (ro)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2440744A1 (de) * 1973-09-11 1975-03-13 Esteve Labor Dr Mono- und diester der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2459614A1 (de) * 1974-05-08 1975-11-20 Esteve Labor Dr Mono-und diester der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2618450A1 (de) * 1975-05-16 1976-11-25 Esteve Labor Dr Salze von diestern der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
FR2747040A1 (fr) * 1996-04-03 1997-10-10 Esteve Labor Dr Derives 2,5-dihydroxybenzenesulfoniques comme medicaments pour normaliser la fonction endotheliale et la fonction sexuelle, et traiter les troubles vasculaires d'origine diabetique ou endotheliale
WO1997037647A1 (fr) * 1996-04-03 1997-10-16 Laboratorios Del Dr. Esteve, S.A. Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550148A (fr) * 1972-05-17 1974-06-14 Esteve Lab Del Dr Sa Procede de preparation de sels d'acides p-dihydroxybenzenedisulfoniques.
ES2015433A6 (es) * 1989-08-03 1990-08-16 Esteve Quimica Sa Procedimientos de preparacion de la sal de piperacina del monotosilato del acido 2,5-dihidroxibencenosulfonico
LT5475B (lt) 2006-04-12 2008-02-25 Laboratorios Del Dr. Esteve, S. A. 2,5-dihidroksibenzensulfoninių junginių panaudojimas sutrikimų, paremtų no produkcijos susilpnėjimu, gydymui ir/arba edhf funkcijos reguliavimo pablogėjimui
EP2313366A2 (en) 2008-01-03 2011-04-27 Action Medicines, S.L. Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242638A (en) * 1968-02-05 1971-08-11 Eastman Kodak Co Dihydroxy-benzene disulphonates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242638A (en) * 1968-02-05 1971-08-11 Eastman Kodak Co Dihydroxy-benzene disulphonates

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2440744A1 (de) * 1973-09-11 1975-03-13 Esteve Labor Dr Mono- und diester der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2459614A1 (de) * 1974-05-08 1975-11-20 Esteve Labor Dr Mono-und diester der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
DE2618450A1 (de) * 1975-05-16 1976-11-25 Esteve Labor Dr Salze von diestern der 2,5-dihydroxybenzolsulfonsaeure, verfahren zu ihrer herstellung und arzneimittel
FR2747040A1 (fr) * 1996-04-03 1997-10-10 Esteve Labor Dr Derives 2,5-dihydroxybenzenesulfoniques comme medicaments pour normaliser la fonction endotheliale et la fonction sexuelle, et traiter les troubles vasculaires d'origine diabetique ou endotheliale
WO1997037647A1 (fr) * 1996-04-03 1997-10-16 Laboratorios Del Dr. Esteve, S.A. Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale
EP1637133A3 (fr) * 1996-04-03 2007-07-11 Laboratorios Del Dr. Esteve, S.A. Utilisation des dérives 2,5-dihydroxybenzènesulfoniques pour la fabrication de médicaments destinés à la normalisation de la fonction endothéliale pour le traitement des complications vasculaires du diabète, ainsi que des troubles vasculaires d'origine endothéliale

Also Published As

Publication number Publication date
GB1419995A (en) 1976-01-07
FR2201888A1 (ro) 1974-05-03
RO72544A (ro) 1981-06-30
ES414365A1 (es) 1976-02-01
FR2201888B1 (ro) 1977-01-21
JPS4941518A (ro) 1974-04-18
AR204506A1 (es) 1976-02-12
NL179186C (nl) 1986-08-01
YU41547B (en) 1987-10-31
NL7306734A (ro) 1973-11-20
RO62887A (fr) 1978-02-15
CS194162B2 (en) 1979-11-30
SE416729B (sv) 1981-02-02
DD107025A5 (ro) 1974-07-12
JPS5716982B2 (ro) 1982-04-08
CA1024146A (en) 1978-01-10
HU169471B (ro) 1976-11-28
DE2323723C2 (ro) 1987-08-13
PL93785B1 (en) 1977-06-30
YU126473A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
DE1695358A1 (de) Derivate des Tris(hydroxymethyl)aminomethans
DE3026201A1 (de) Aminoaetheroxide, verfahren zu ihrer herstellung sowie ihre therapeutische verwendung
DE2445584A1 (de) Aminosaeureester
CH395136A (de) Verfahren zur Herstellung von Xanthenen oder Thiaxanthenen
DE2323723A1 (de) Verfahren zur herstellung von neuen derivaten der p-dihydroxybenzoldisulfonsaeure
DE2253750C3 (de) Apovincaminsaure-alkylester, Verfahren zu ihrer Herstellung und pharmazeutische
CH621116A5 (ro)
DE2548508C2 (ro)
DE3538063C2 (ro)
DE1149010B (de) Verfahren zur Herstellung von 1-[2-Alkyl-4-aminopyrimidyl-(5)-methyl]-alkylpyridiniumsalzen
DE1668385A1 (de) Quaternaere Semicarbazon-und Thiosemicarbazon-Salze
DE2148986A1 (de) Chondroitinschwefelsaeuresalze und ein Verfahren zu ihrer Herstellung
DE2511576A1 (de) Metformin-clofibrat, verfahren zu seiner herstellung und es enthaltendes arzneimittel
AT201603B (de) Verfahren zur Herstellung der neuer Piperazo[c]pyridazin-Verbindungen
AT229874B (de) Verfahren zur Herstellung von neuen (5- oder 6)-Alkyl- und 5, 6-Dialkyl-3-alkoxy-pyrazinen
DE2264979A1 (de) Thiazolo- eckige klammer auf 3.2-a eckige klammer zu -pyrimderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE1936670C3 (de) S-Diallylaminoalkanoyl-SJO-dihydro-11H-dibenzo eckige Klammer auf b,e eckige Klammer zu- eckige Klammer auf 1,4 eckige Klammer zu diazepin-11-onderivate
AT229313B (de) Verfahren zur Herstellung von neuen Nikotinoyl- und Isonikotinoyl-mono- und -dibenzylaminen
CH629777A5 (de) Verfahren zur herstellung von 3-niedrigalkoxy-cyproheptadinen.
AT225196B (de) Verfahren zur Herstellung des neuen 2,4-Diamino-1-p-chlorphenyl-6,6-3'-methylpentamethylen-1,6-dihydro-s-triazins und seiner Säureadditionssalze
AT360007B (de) Verfahren zur herstellung von 2-(phenylamino)- imidazolin-(2)derivaten und deren salzen
AT244954B (de) Verfahren zur Herstellung von neuen Succinimidverbindungen
CH581656A5 (ro)
DE1470160C (de) 2-Chlor-9-piperazinopropyliden-thioxanthene und ein Verfahren zu ihrer Herstellung
DE2022790C3 (de) 10-Methyl-5-[ (4-Methylpiperazino)-acetyl J-5,10dihydro-llH-dibenzo [b,e ] [1,4 ] diazepin-11-on, ein Verfahren zu dessen Herstellung sowie dieses enthaltende Arzneimittel

Legal Events

Date Code Title Description
OD Request for examination
8127 New person/name/address of the applicant

Owner name: PROVESAN S.A., GENF/GENEVE, CH

8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. VOSSIUS, D.,

D2 Grant after examination
8364 No opposition during term of opposition